Epigenome-wide association studies identify novel DNA methylation sites associated with PTSD: A meta-analysis of 23 military and civilian cohorts

Seyma Katrinli,Agaz H Wani,Adam X Maihofer,Andrew Ratanatharathorn,Nikolaos P Daskalakis,Janitza Montalvo-Ortiz,Diana L Nunez-Rios,Anthony S Zannas,Xiang Zhao,Allison E Aiello,Allison E Ashley-Koch,Diana Avetyan,Dewleen G Baker,Jean C Beckham,Marco P Boks,Leslie A Brick,Evelyn Bromet,Frances A Champagne,Chia-Yen Chen,Shareefa Dalvie,Michelle F Dennis,Segun Fatumo,Catherine Fortier,Sandro Galea,Melanie E Garrett,Elbert Geuze,Gerald Grant,Michael A Hauser,Jasmeet P Hayes,Sian MJ Hemmings,Bertrand Russel Huber,Aarti Jajoo,Stefan Jansen,Ronald C Kessler,Nathan A Kimbrel,Anthony P King,Joel E Kleinman,Nastassja Koen,Karestan C Koenen,Pei-Fen Kuan,Israel Liberzon,Sarah D Linnstaedt,Adriana Lori,Benjamin J Luft,Jurjen J Luykx,Christine E Marx,Samuel A McLean,Divya Mehta,William Milberg,Mark W Miller,Mary S Mufford,Clarisse Musanabaganwa,Jean Mutabaruka,Leon Mutesa,Charles B Nemeroff,Nicole R Nugent,Holly K Orcutt,Xue-Jun Qin,Sheila AM Rauch,Kerry J Ressler,Victoria B Risbrough,Eugene Rutembesa,Bart PF Rutten,Soraya Seedat,Dan J Stein,Murray B Stein,Sylvanus Toikumo,Robert J Ursano,Annette Uwineza,Mieke H Verfaellie,Eric Vermetten,Christiaan H Vinkers,Erin B Ware,Derek E Wildman,Erika J Wolf,Ross McD Young,Ying Zhao,Leigh L van den Heuvel,PGC-PTSD Epigenetics Workgroup,PsychENCODE PTSD Brainomics Project,Traumatic Stress Brain Research Group,Monica Uddin,Caroline M Nievergelt,Alicia K Smith,Mark W Logue
DOI: https://doi.org/10.1101/2024.07.15.24310422
2024-07-15
Abstract:Background: The occurrence of post-traumatic stress disorder (PTSD) following a traumatic event is associated with biological differences that can represent the susceptibility to PTSD, the impact of trauma, or the sequelae of PTSD itself. These effects include differences in DNA methylation (DNAm), an important form of epigenetic gene regulation, at multiple CpG loci across the genome. Moreover, these effects can be shared or specific to both central and peripheral tissues. Here, we aim to identify blood DNAm differences associated with PTSD and characterize the underlying biological mechanisms by examining the extent to which they mirror associations across multiple brain regions. Methods: As the Psychiatric Genomics Consortium (PGC) PTSD Epigenetics Workgroup, we conducted the largest cross-sectional meta-analysis of epigenome-wide association studies (EWASs) of PTSD to date, involving 5077 participants (2156 PTSD cases and 2921 trauma-exposed controls) from 23 civilian and military studies. PTSD diagnosis assessments were harmonized following the standardized guidelines established by the PGC-PTSD Workgroup. DNAm was assayed from blood using either Illumina HumanMethylation450 or MethylationEPIC (850K) BeadChips. A common QC pipeline was applied. Within each cohort, DNA methylation was regressed on PTSD, sex (if applicable), age, blood cell proportions, and ancestry. An inverse variance-weighted meta-analysis was performed. We conducted replication analyses in tissue from multiple brain regions, neuronal nuclei, and a cellular model of prolonged stress. Results: We identified 11 CpG sites associated with PTSD in the overall meta-analysis (1.44e-09 < p < 5.30e-08), as well as 14 associated in analyses of specific strata (military vs civilian cohort, sex, and ancestry), including CpGs in AHRR and CDC42BPB. Many of these loci exhibit blood-brain correlation in methylation levels and cross-tissue associations with PTSD in multiple brain regions. Methylation at most CpGs correlated with their annotated gene expression levels. Conclusions: This study identifies 11 PTSD-associated CpGs, also leverages data from postmortem brain samples, GWAS, and genome-wide expression data to interpret the biology underlying these associations and prioritize genes whose regulation differs in those with PTSD.
Psychiatry and Clinical Psychology
What problem does this paper attempt to address?
The paper attempts to address the issue of identifying novel DNA methylation sites associated with post-traumatic stress disorder (PTSD) and exploring the biological mechanisms of these sites in different tissues. Specifically, the study aims to determine PTSD-related DNA methylation differences in blood through large-scale epigenome-wide association studies (EWAS) and verify whether these differences also exist in multiple brain regions. ### Main Research Questions: 1. **Identify DNA methylation sites associated with PTSD**: Identify DNA methylation sites significantly associated with PTSD through large-scale epigenome-wide association studies. 2. **Verify the biological relevance of these sites in different tissues**: Verify whether these DNA methylation sites are also associated with PTSD in different tissues by analyzing data from multiple brain regions, neuronal nuclei, and long-term stress cell models. 3. **Explain the biological mechanisms of these sites**: Explain the biological significance of these DNA methylation sites using post-mortem brain samples, genome-wide association studies (GWAS), and genome-wide expression data, prioritizing those that regulate different genes in PTSD patients. ### Research Background: - **Biological basis of PTSD**: PTSD is a severe psychological disorder characterized by intrusive trauma memories, avoidance or numbness to trauma-related contexts, and hyperarousal symptoms that can affect mental and physical health. - **Genetic and environmental factors**: Although most people experience at least one traumatic event in their lifetime, only a few develop PTSD. Genetic and environmental factors jointly determine an individual's susceptibility to trauma exposure. - **Importance of epigenetics**: Epigenetics, particularly DNA methylation, is an important gene regulatory mechanism that can respond to environmental changes, is reversible, and can serve as a target for disease treatment. Studies have shown that trauma exposure can alter epigenetic patterns, necessitating epigenetic research on PTSD. ### Research Methods: - **Sample selection**: The study includes 5077 participants from 23 military and civilian cohorts, with 2156 PTSD cases and 2921 trauma-exposed controls. - **DNA methylation detection**: Whole blood DNA methylation was detected using the Illumina HumanMethylation450 or MethylationEPIC (850K) BeadChip. - **Data analysis**: Standardized quality control pipelines were applied, and multivariable linear regression models were used to analyze the relationship between DNA methylation and PTSD in each cohort, followed by inverse variance-weighted meta-analysis. ### Results: - **Identified 11 CpG sites significantly associated with PTSD**: These sites showed significant associations in the overall meta-analysis, with some sites also showing significant associations in specific subgroups (e.g., military vs. civilian cohorts, gender, and ancestry). - **Cross-tissue validation**: Many of these sites showed correlated methylation levels in blood and multiple brain regions and were associated with the expression levels of annotated genes. ### Conclusion: - **Identified 11 CpG sites associated with PTSD**: These sites were significantly associated not only in blood but also showed similar associations in multiple brain regions. - **Explanation of biological mechanisms**: The biological significance of these sites was explained by combining post-mortem brain samples, GWAS, and genome-wide expression data, prioritizing those that regulate different genes in PTSD patients. In summary, this study identified novel DNA methylation sites associated with PTSD through large-scale epigenome-wide association studies and validated the biological relevance of these sites in different tissues, providing important clues for further understanding the biological mechanisms of PTSD.